The interrelationships of thyroid hormone, the adrenal medulla, and the sympathetic nervous system have been recognized since the early part of the present century (1-4). More recent studies of experimental hyperthyroidism by Brewster, Isaacs, Osgood, and King (5) supported the hypothesis that the sympathetic nervous system may be responsible for the metabolic and hemodynamic changes associated with the hypermetabolic state, since the alterations induced by thyroid feeding could be reversed by epidural block.
The interrelationships of thyroid hormone, the adrenal medulla, and the sympathetic nervous system have been recognized since the early part of the present century (1) (2) (3) (4) . More recent studies of experimental hyperthyroidism by Brewster, Isaacs, Osgood, and King (5) supported the hypothesis that the sympathetic nervous system may be responsible for the metabolic and hemodynamic changes associated with the hypermetabolic state, since the alterations induced by thyroid feeding could be reversed by epidural block.
Recent trials of reserpine (6, 7) and guanethidine (7-9) that release catecholamines and deplete the tissues of them have shown that these drugs can partially alleviate some clinical manifestations of thyrotoxicosis. ' The cardiac rate may be slowed, but consistent and significant reductions of the high cardiac output in patients with hyperthyroidism have not been reported, except by Goldstein, Furth, Becker, and Killip (10) using guanethidine. Methyldopa, a decarboxylase inhibitor, also slows the pulse rate of patients with hyperthyroidism, but does not significantly change the clinical manifestations (11) , or reduce the elevated cardiac output or oxygen consumption (12) . Furthermore, a continuous infusion of phentolamine (Regitine) in a hyperthyroid patient does not alter cardiac output (13) , since it blocks alpha-rather than beta-adrenergic receptors. If the sympathetic nervous system is a crucial mediator of the hemodynamic changes in hyperthyroidism, it seems logical to explore the part that beta *Submitted for publication March 16, 1964; accepted April 23, 1964. This study was presented in part at the Annual Meeting of the Midwestern Section of the American Federation for Clinical Research, Chicago, Ill., October 31, 1963. (Clin. Res. 1963, 11, 300 .) It was supported by grants from the Iowa Heart Association and the National Heart Institute (U. S. Public Health Service grant 5T1-HE-5577-02).
receptor activity plays in the accelerated cardiac output and the tachycardia. The purpose of this paper is to present our observations on the pharmacodynamic effects of nethalide (2-isopropylamino--[2-naphthyl] ethanol hydrochloride), a drug that blocks beta-adrenergic receptors in patients with spontaneous hyperthyroidism.
Methods
All patients studied were from the wards of the University Hospitals, Iowa City. There were seven women and four men. They ranged in age from 19 to 54 years (mean, 32.5) and in body surface area from 1.40 to 1.83 m2 (mean, 1.65). All had classic manifestations of hyperthyroidism but no signs of heart failure or arrhythmia.
The protein-bound iodine averaged 13.1 /Ag per 100 ml serum, and the 24-hour uptake of I' varied from 56 to 92% (mean, 72.8%). No patient had received antithyroid drugs for at least 1 month before these studies. Each patient received a 2,500 calorie diet.
Hemodynamic responses to beta-adrenergic receptor stimulation by isoproterenol hydrochloride were recorded in seven hyperthyroid patients before and after nethalide (1 mg per kg iv). Heart rate, cardiac output, and systemic arterial and mean right atrial pressures were recorded before and during the fourth minute of infusion of isoproterenol at two dose levels, before and 10 minutes after nethalide. (14) . In this study a p value of < 0.05 was the criterion for statistical significance.
Results
General. The infusions of isoproterenol were well tolerated by all of the patients. Many of them were aware of palpitation and pounding of the heart, especially during infusion of the larger dose of isoproterenol. These Oxygen consumption, ml/min/m2 183 ± 19 189 ± 9 * Six of the hyperthyroid patients who received nethalide (iv) (A) and one additional hyperthyroid patient were studied again after oral nethalide (B).
t Nethalide, given iv or orally, produced effective beta-adrenergic blockade (Figures 1, 2 ), but did not alter the cardiac hemodynamics or the oxygen consumption of these hyperthyroid patients. None of the postdrug values was significantly different from control.
Effects of isoproterenol before and after intravenous nethalide. The effects of isoproterenol on heart rate, cardiac index, and systemic mean arterial and mean right atrial pressures before and after administration of nethalide (1 mg per kg iv) are shown in Figure 1 . Before nethalide, isoproterenol at the two dose levels significantly increased heart rate from an average of 103 to 120 and 136 beats per minute, respectively. After nethalide, the mean heart rate varied from a control rate of 109 to 107 and 105 beats per minute in response to the two dose levels of isoproterenol, respectively. Mean right atrial pressure before the beta-adrenergic blocking drug averaged 3.5 mm Hg (in five of seven subjects in which it was measured). It tended to fall during isoproterenol infusions in each subject, but the changes were not of sufficient magnitude to achieve statistical significance as defined for this study (actual p value < 0.10). After nethalide this reduction in right atrial pressure during isoproterenol tended to be less. Heart rate, cardiac output, and systemic mean arterial and right atrial pressures after nethalide were not significantly different from their respective controls, although effective beta-receptor blockade had been induced ( Figure 1 and Table I ).
Effects of isoproterenol before and after oral nethalide. Figure 2 shows the effects of isoproterenol on heart rate, cardiac index, and systemic mean arterial and mean right atrial pressures before and after 3 to 7 days of nethalide, given orally, 600 to 800 mg per day, in four doses at intervals of 6 hours. Before nethalide isoproterenol increased heart rate from 103 to 119 receptor blockade, nethalide alone did not alter the average control heart rate, cardiac index, and systemic mean arterial or mean right atrial pressures ( Figure 2 and Table I ).
Placebo effects, acute and chronic. The effects of isoproterenol on the individual heart rates, cardiac indexes, and mean arterial and mean right atrial pressures of three additional patients before, 10 minutes after intravenous infusion of 10 ml of isotonic saline solution, and 3 days after oral administration of nethalide placebos at intervals of 6 hours, are shown in Figures 3 and 4 . Responses to isoproterenol after the placebos were similar to those obtained in the control period regardless of the route of administration.
Effect of nethalide on oxygen consumption. Black and Stephenson (15) . They reported that it blocked the increase in heart rate produced by infusion of catecholamines and that it had no intrinsic sympathomimetic activity. Bradycardia was common in unanesthetized animals and was attributed to myocardial adrenergic blockade. Dornhorst and Robinson (16) showed that the heart rate usually is slowed by the drug at rest and always on exercise in normal man and in patients with ischemic heart disease. Harrison and co-workers (17) What then is the explanation for the basic circulatory changes in the thyrotoxic patient? The "exaggerated" response of thyrotoxic patients to exogenous pressor amines does not necessarily imply that the effects of thyroid hormone are mediated directly by action of this hormone on the sympathetic nervous system and its adrenergic receptors. Perhaps the only difference between the thyrotoxic patient and the normal subject in response to catecholamines is the level of the starting point rather than the increments in heart rate and cardiac output. Uncoupling of oxidative phosphorylation is said to occur in thyrotoxicosis. Impaired oxygen utilization could produce relative tissue hypoxia. Hypoxia and perhaps accumulation of certain metabolites might induce vasodilatation in the peripheral tissues. Such a phenomenon if of sufficient magnitude could activate baroreceptor and other neural or humoral reflexes leading to an increased heart rate and increased cardiac output to maintain homeostasis. Such considerations do not exclude the possibility of direct effects of thyroid hormone on the sinus node or other cardiac tissues.
Summary
Effective beta-adrenergic receptor blockade by nethalide, given intravenously or orally, was produced in patients with hyperthyroidism. Despite inhibition of the chronotropic and inotropic effects of isoproterenol, nethalide did not significantly change oxygen consumption, heart rate, cardiac output, and systemic mean arterial or mean right atrial pressures in these patients. These findings do not support the hypothesis that the hemodynamic changes in hyperthyroidism are mediated through adrenergic stimulation of beta-adrenergic receptors.
